SRSF2 and acute myeloid leukemia: On the other hand, ASXL1 and SRSF2 mutations were more commonly detected in AML-MRC-M compared to AML-MRC-C (p = 0.032 and 0.024, respectively) and were frequently co-mutated (55%, 6/11, p < 0.001).